about
Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemiaEfficacy and Safety of Intravenous Ferric Carboxymaltose in Geriatric Inpatients at a German Tertiary University Teaching Hospital: A Retrospective Observational Cohort Study of Clinical Practice.Iron Deficiency in Long-Term Parenteral Nutrition Therapy.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intravenous iron in oncology.
@en
Intravenous iron in oncology.
@nl
type
label
Intravenous iron in oncology.
@en
Intravenous iron in oncology.
@nl
prefLabel
Intravenous iron in oncology.
@en
Intravenous iron in oncology.
@nl
P356
P1476
Intravenous iron in oncology.
@en
P2093
Harold Ballard
Michael Auerbach
P304
585-92; quiz 592
P356
10.6004/JNCCN.2008.0045
P577
2008-07-01T00:00:00Z